TXG

10x Genomics, Inc. Class A Common Stock

90.14

USD

+1.64

+1.85%

Sep 29, 15:54 UTC -4

Open

TXG Earnings Reports

Positive Surprise Ratio

TXG beat 16 of 28 last estimates.

57%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$149.17M

-$0.26

Implied change from Q2 26 (Revenue/ EPS)

-1.23%

+85.71%

Implied change from Q3 25 (Revenue/ EPS)

+0.11%

+18.18%

10x Genomics, Inc. Class A Common Stock earnings per share and revenue

On Aug 06, 2026, TXG reported earnings of -0.14 USD per share (EPS) for Q2 26, beating the estimate of -0.24 USD, resulting in a 43.09% surprise. Revenue reached 151.04 million, compared to an expected 148.26 million, with a 1.88% difference. The market reacted with a +14.10% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 16 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 149.17 million USD, implying an increase of 85.71% EPS, and decrease of -1.23% in Revenue from the last quarter.

FAQ

What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.14, beating estimates by 43.09%, and revenue of $151.04M, 1.88% above expectations.

How did the market react to 10x Genomics, Inc. Class A Common Stock's Q2 2026 earnings?

The stock price moved up 14.1%, changed from $45.60 before the earnings release to $52.03 the day after.

When is 10x Genomics, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?

Based on 16 analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.26 and revenue of $149.17M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.